BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36371223)

  • 1. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
    Zhang X; Wen X; Feng N; Chen A; Yao S; Ding X; Zhang L
    Med Sci Monit; 2020 Jun; 26():e923087. PubMed ID: 32561704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
    Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
    Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
    Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
    Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma.
    Zhang W; Wang S
    Melanoma Res; 2024 Jun; 34(3):215-224. PubMed ID: 38364052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications.
    Zhang Y; Gao C; Luo J; Khan A; Salem-Bekhit MM; Salem MM; Qi Z; Jiang B
    Int Wound J; 2024 Apr; 21(4):e14807. PubMed ID: 38591163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of tumor microenvironment infiltration and the identification of angiogenesis-related subgroups in skin cutaneous melanoma.
    Li J; Ren H; Huai H; Li J; Xie P; Li X
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7259-7273. PubMed ID: 36912943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
    Zhang ZG; Zhu HM; Hua HK
    Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic role of sphingosine 1-phosphate receptor 4 (S1PR4) as a biomarker of skin cutaneous melanoma.
    Wang Z; Pan F; Zhang G
    Heliyon; 2024 Mar; 10(5):e27505. PubMed ID: 38468937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning-derived immunosenescence index for predicting outcome and drug sensitivity in patients with skin cutaneous melanoma.
    Zhu L; Zhang L; Qi J; Ye Z; Nie G; Leng S
    Genes Immun; 2024 May; ():. PubMed ID: 38811681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from
    Kałuzińska-Kołat Ż; Kołat D; Kośla K; Płuciennik E; Bednarek AK
    Front Neurosci; 2023; 17():1260409. PubMed ID: 37781246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics.
    Qin P; Huang H; Wang J; Jiang T; Zeng N; Wang Q; He Y; Zhou Y
    Med Oncol; 2023 Aug; 40(9):276. PubMed ID: 37612479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
    Sun X; Zhang J; Xiao C; Ge Z
    BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
    Sun X; Zhang J; Hu J; Han Q; Ge Z
    BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.